Literature DB >> 16565758

Angiographic characteristics of acute central serous chorioretinopathy in an Asian population.

Alicia C S W How1, Adrian H C Koh.   

Abstract

INTRODUCTION: Acute central serous chorioretinopathy (CSCR) afflicts young middle-aged males in the Western population. We aimed to analyse patient demographics and to determine the angiographic characteristics of acute CSCR in an Asian population.
MATERIALS AND METHODS: This is a retrospective study of all patients presenting with acute CSCR who had fundal fluorescein angiograms performed within a 4-year period (between 1 January 1998 and 31 December 2001).
RESULTS: The fluorescein angiograms of 128 patients were analysed. The majority were male (109/128) with a male-to-female ratio of 5.7:1. The age range of patients was 26 to 60 years, with a mean age of 41 years. The majority of patients (84%) were aged 30 to 50 years. With regard to racial distribution, 83% were Chinese, 6% were Malays and 11% were Indians or of other races. Unilateral disease was found in 74 patients (58%) and 52 had bilateral disease. The macula was the most common site of fluorescein leakage and was found in 97 patients (76%). Almost half the patients (44%) had more than one site of disease involvement (i.e., multifocal). The inkblot leakage pattern was found in 103 patients (80%).
CONCLUSIONS: The patient demographics of acute CSCR in our population were compared to that reported in the West. The gender ratio was similar, with males being afflicted 6 to 10 times more compared to females. There was no racial predilection found for acute CSCR in the local population. We also found a significant proportion of patients with bilateral and multifocal disease compared to the West. The inkblot pattern of leakage was the most common pattern seen on angiography. There were a significant number of cases with bilateral and multifocal involvement, exceeding those reported in non-Asian populations.

Entities:  

Mesh:

Year:  2006        PMID: 16565758

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  12 in total

1.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

2.  Central serous chorioretinopathy: from glucocorticoids to light intensity.

Authors:  Amir Norouzpour; Majid Abrishami
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

3.  Angiographic characteristics of central serous chorioretinopathy in an Egyptian population.

Authors:  Maha M Shahin
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

4.  Diagnosed a Patient with Central Serous Chorioretinopathy? Now What?: Management of Central Serous Chorioretinopathy.

Authors:  Brian E Goldhagen; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2017-05-08

5.  Smokestack leak in central serous chorioretinopathy.

Authors:  Dhiren Bujarborua; Pran N Nagpal; Manab Deka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-15       Impact factor: 3.117

6.  Quality of life of patients with central serous chorioretinopathy - a major cause of vision threat among middle-aged individuals.

Authors:  Izabella Karska-Basta; Weronika Pociej-Marciak; Michał Chrząszcz; Katarzyna Żuber-Łaskawiec; Marek Sanak; Bożena Romanowska-Dixon
Journal:  Arch Med Sci       Date:  2020-01-29       Impact factor: 3.318

7.  Systemic factors associated with central serous chorioretinopathy in Koreans.

Authors:  Youngsub Eom; Jaeryung Oh; Seong-Woo Kim; Kuhl Huh
Journal:  Korean J Ophthalmol       Date:  2012-07-24

8.  Factors affecting the visual outcome in acute central serous chorioretinopathy.

Authors:  Qamar Ul Islam; Muhammad Asad Farooq; Mohammad Asim Mehboob
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

Review 9.  Central serous chorioretinopathy: Current update on pathophysiology and multimodal imaging.

Authors:  George Joseph Manayath; Ratnesh Ranjan; Vanee Sheth Shah; Smita S Karandikar; Veerappan R Saravanan; Venkatapathy Narendran
Journal:  Oman J Ophthalmol       Date:  2018 May-Aug

Review 10.  Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature.

Authors:  Irini Chatziralli; Aikaterini Vlachodimitropoulou; Chrysoula Daoula; Christina Vrettou; Eleni Galani; George Theodossiadis; Panagiotis Theodossiadis
Journal:  Int J Retina Vitreous       Date:  2018-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.